Latest Ratings for BURL Date Firm Action From To Mar 2022 Truist Securities Maintains Buy Mar 2022 Morgan Stanley Maintains Overweight Mar 2022 Deutsche Bank Maintains Buy View More Analyst Ratings for BURL View the Latest Analyst Ratings read more Latest Ratings for BURL DateFirmActionFromTo Mar 2022Truist SecuritiesMaintainsBuy Mar 2022Morgan StanleyMaintainsOverweight Mar 2022Deutsche BankMaintainsBuy
Latest Ratings for GLPI Date Firm Action From To Jan 2022 Berenberg Initiates Coverage On Buy Jan 2022 Morgan Stanley Maintains Overweight Jan 2022 B of A Securities Downgrades Buy Underperform View More Analyst Ratings for GLPI View the Latest Analyst Ratings read more Latest Ratings for GLPI DateFirmActionFromTo Jan 2022BerenbergInitiates Coverage OnBuy Jan
Latest Ratings for SE Date Firm Action From To Mar 2022 JP Morgan Downgrades Overweight Neutral Mar 2022 Barclays Maintains Overweight Feb 2022 JP Morgan Maintains Overweight View More Analyst Ratings for SE View the Latest Analyst Ratings read more Latest Ratings for SE DateFirmActionFromTo Mar 2022JP MorganDowngradesOverweightNeutral Mar 2022BarclaysMaintainsOverweight Feb 2022JP MorganMaintainsOverweight View
Latest Ratings for DUOL Date Firm Action From To Mar 2022 Evercore ISI Group Maintains Outperform Mar 2022 Piper Sandler Maintains Overweight Jan 2022 Piper Sandler Maintains Overweight View More Analyst Ratings for DUOL View the Latest Analyst Ratings read more Latest Ratings for DUOL DateFirmActionFromTo Mar 2022Evercore ISI GroupMaintainsOutperform Mar 2022Piper SandlerMaintainsOverweight Jan
NVIDIA ranked No. 1 on Forbes magazine’s new list — America’s Best Companies — based on more than 60 measures in nearly a dozen categories that cover financial performance, customer and employee satisfaction, sustainability, remote work policies and more. Forbes stated that the company thrived in numerous areas, “particularly employee satisfaction, earning high ratings in
Diabetics — or others monitoring their sugar intake — may look at a cookie and wonder, “How will eating this affect my glucose levels?” A generative AI model can now predict the answer. Researchers from the Weizmann Institute of Science, Tel Aviv-based startup Pheno.AI and NVIDIA led the development of GluFormer, an AI model that
This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.